Robert W. Baird Forecasts Strong Price Appreciation for Healthpeak Properties (NYSE:DOC) Stock

Healthpeak Properties (NYSE:DOC) had its price objective raised by equities research analysts at Robert W. Baird from $19.00 to $21.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s target price would suggest a potential upside of 6.21% from the stock’s current price.

Several other equities research analysts have also recently weighed in on DOC. Citigroup boosted their target price on Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a research note on Tuesday. Scotiabank upgraded Healthpeak Properties to a “hold” rating in a research note on Thursday, April 23rd. UBS Group assumed coverage on Healthpeak Properties in a research report on Monday, April 20th. They set a “neutral” rating and a $17.00 price target on the stock. Argus lowered Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Finally, Morgan Stanley cut their price target on Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 28th. Four research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $18.58.

Healthpeak Properties Price Performance

DOC stock opened at $19.77 on Wednesday. The business has a 50 day moving average price of $17.15 and a 200 day moving average price of $17.18. The stock has a market cap of $13.63 billion, a price-to-earnings ratio of 61.79, a PEG ratio of 2.73 and a beta of 1.00. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $19.87. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities research analysts anticipate that Healthpeak Properties will post 1.74 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. WPG Advisers LLC increased its position in Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 1,197 shares during the period. Advocate Investing Services LLC acquired a new position in Healthpeak Properties during the fourth quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in shares of Healthpeak Properties in the fourth quarter valued at approximately $31,000. Clearstead Advisors LLC increased its holdings in shares of Healthpeak Properties by 166.3% in the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after purchasing an additional 1,216 shares during the period. Finally, CYBER HORNET ETFs LLC acquired a new position in shares of Healthpeak Properties in the second quarter valued at approximately $33,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.